Skip to Content

R419 (Lamotrigine Extended-Release 250 mg)

Pill with imprint R419 is Purple, Elliptical / Oval and has been identified as Lamotrigine Extended-Release 250 mg. It is supplied by Dr. Reddy's Laboratories, Inc..

Lamotrigine is used in the treatment of bipolar disorder; schizoaffective disorder; seizure prevention; epilepsy and belongs to the drug class triazine anticonvulsants. Risk cannot be ruled out during pregnancy. Lamotrigine 250 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for R419

Lamotrigine extended-release 250 mg R419

Lamotrigine Extended-Release

250 mg
16.00 mm
Elliptical / Oval
Prescription only
Drug Class
Triazine anticonvulsants
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Dr. Reddy's Laboratories, Inc.
National Drug Code (NDC)
Inactive Ingredients
hypromelloses, lactose monohydrate, magnesium stearate, polyethylene glycol 400, magnesium silicate, titanium dioxide, triethyl citrate, shellac, methacrylic acid - ethyl acrylate copolymer (1:1) type a, FD&C Blue No. 2, D&C Red No. 27, ferrosoferric oxide

Note: Inactive ingredients may vary.

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.